Elevated levels of procoagulant MVs and tissue factor (TF)-bearing MVs in COVID-19 patients have been suggested as early potential markers for predicting disease severity
This has led researchers to investigate medications that modulate these systems, including the glucagon-like peptide-1 (GLP-1) receptor agonists originally developed for type 2 diabetes and obesity management
Open Forum Infect Dis
Effects of L-carnitine on obesity, diabetes, and as an ergogenic aid
Victoza may contribute to an increased risk for thyroid c-cell tumors, acute pancreatitis, gallbladder disease, hypoglycemia, acute kidney injury, severe GI side effects, hypersensitivity reactions, increased heart rate, abdominal pain, reflux, gas and dizziness
Immunolocalization and adenoviral vector-mediated manganese superoxide dismutase gene transfer to experimental oral tumors